CARILEX MEDICAL INC. (7726) Stock Statistics & Valuation Metrics
Total Valuation
CARILEX MEDICAL INC. has a market cap or net worth of TWD 652.77M. The enterprise value is ―.
- Market Cap
- TWD 652.77M
- Enterprise Value
- ―
Share Statistics
CARILEX MEDICAL INC. has 20,304,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 20,304,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
CARILEX MEDICAL INC.’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -6.71%.
- Return on Equity (ROE)
- -0.10
- Return on Assets (ROA)
- -0.05
- Return on Invested Capital (ROIC)
- -6.71%
- Return on Capital Employed (ROCE)
- -0.14
- Revenue Per Employee
- 2.26M
- Profits Per Employee
- -193.20K
- Employee Count
- 150
- Asset Turnover
- 0.63
- Inventory Turnover
- 2.49
Valuation Ratios
The current PE Ratio of CARILEX MEDICAL INC. is -52.70. CARILEX MEDICAL INC.’s PEG ratio is -0.53.
- PE Ratio
- -52.70
- PS Ratio
- 1.72
- PB Ratio
- 2.22
- Price to FCF
- 16.54
- Price to Operating Cash Flow
- 14.58
- PEG Ratio
- -0.53
Income Statement
In the last 12 months, CARILEX MEDICAL INC. had revenue of 338.63M and earned -28.98M in profits. Earnings per share was -1.43.
- Revenue
- 338.63M
- Gross Profit
- 99.11M
- Operating Income
- -42.76M
- Pretax Income
- -39.39M
- Net Income
- -28.98M
- EBITDA
- -5.43M
- Earnings Per Share (EPS)
- -1.43
Cash Flow
In the last 12 months, operating cash flow was 45.09M and capital expenditures -5.63M, giving a free cash flow of 39.46M billion.
- Operating Cash Flow
- 45.09M
- Free Cash Flow
- 39.46M
- Free Cash Flow per Share
- 1.93
Dividends & Yields
CARILEX MEDICAL INC. pays an annual dividend of ―, resulting in a dividend yield of 1.77%
- Dividend Per Share
- ―
- Dividend Yield
- 1.77%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.05%
- Earnings Yield
- -1.89%
Stock Price Statistics
- Beta
- -0.01
- 52-Week Price Change
- -15.28%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 77.86
- Average Volume (3m)
- 200
Financial Position
CARILEX MEDICAL INC. as a current ratio of 1.95, with Debt / Equity ratio of 59.17%
- Current Ratio
- 1.95
- Quick Ratio
- 1.52
- Debt to Market Cap
- 0.16
- Net Debt to EBITDA
- 9.60
- Interest Coverage Ratio
- -17.04
Taxes
In the past 12 months, CARILEX MEDICAL INC. has paid -10.41M in taxes.
- Income Tax
- -10.41M
- Effective Tax Rate
- 0.26
Enterprise Valuation
CARILEX MEDICAL INC. EV to EBITDA ratio is -93.36, with an EV/FCF ratio of 14.58.
- EV to Sales
- 1.51
- EV to EBITDA
- -93.36
- EV to Free Cash Flow
- 14.58
- EV to Operating Cash Flow
- 12.76
Balance Sheet
CARILEX MEDICAL INC. has TWD 206.13M in cash and marketable securities with TWD 128.57M in debt, giving a net cash position of TWD 77.56M billion.
- Cash & Marketable Securities
- TWD 206.13M
- Total Debt
- TWD 128.57M
- Net Cash
- TWD 77.56M
- Net Cash Per Share
- TWD 3.82
- Tangible Book Value Per Share
- TWD 13.84
Margins
Gross margin is 27.11%, with operating margin of -10.95%, and net profit margin of -3.27%.
- Gross Margin
- 27.11%
- Operating Margin
- -10.95%
- Pretax Margin
- -6.19%
- Net Profit Margin
- -3.27%
- EBITDA Margin
- -1.62%
- EBIT Margin
- -10.95%
Analyst Forecast
The average price target for CARILEX MEDICAL INC. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 18.79%
- EPS Growth Forecast
- -92.61%
